In this study, we showed that MTUS1 expression was significantly lower in lung adenocarcinoma tissues with adverse clinicopathological features, and we confirmed that the prognosis in terms of DFS and CSS was significantly worse in patients with lower MTUS1 expression, especially in patients at early stages and without additional treatment. Here, MTUS1 is linked to lung adenocarcinoma.